5-Methoxymethyl-2'-deoxycytidine (MMdCyd) and the corresponding deoxyuridine analogue, 5-methoxymethyl-2'-deoxyuridine (MMdUrd) are selective antiherpesvirus agents. MMdCyd (ED 50 1.5~lM) is a more potent inhibitor of herpes simplex virus replication than MMdUrd (ED 5o 30~lM) when maintained in the deoxycytidine form (deamination prevented). The 5'-triphosphates, MMdCTP and MMdUTP, were synthesized, and incorporation into DNA. by mitochondrial DNA polymerase y was investigated. MMdcTPand MMdUTP were incorporated into DNA in place of dCTP and dTTP, respectively. The effect of MMdCyd and MMdUrd on cell growth (acute toxicity) and proloriged exposure (delayed cytotoxicity) in CEM cells was investigated. The two analogues did not exhibit acute or delayed toxicity (2 weeks exposure) up to 1000~lM. In contrast, at a concentration as low as 0.125~lM of 2' )'-dideoxycytidine (ddC; control druq], the doubling time of the cells increased after 10 days. At higher concentrations, a very marked increase in doubling time was observed from 6 days onward with ddC treatment. The data suggest that in uninfected cells neitherMMdUrd nor MMdCyd are anabolized to the triphosphate Form in signiFicant amounts. As a result, little or no MMdCTP or MMdUTP builds up in the mitochondria and thus delayed toxicity is not observed.
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Summary 5-Methoxymethyl-2'-deoxycytidine (MMdCyd) and the corresponding deoxyuridine analogue, 5-methoxymethyl-2'-deoxyuridine (MMdUrd) are selective antiherpesvirus agents. MMdCyd (ED 50 1.5~lM) is a more potent inhibitor of herpes simplex virus replication than MMdUrd (ED 5o 30~lM) when maintained in the deoxycytidine form (deamination prevented). The 5'-triphosphates, MMdCTP and MMdUTP, were synthesized, and incorporation into DNA. by mitochondrial DNA polymerase y was investigated. MMdcTPand MMdUTP were incorporated into DNA in place of dCTP and dTTP, respectively. The effect of MMdCyd and MMdUrd on cell growth (acute toxicity) and proloriged exposure (delayed cytotoxicity) in CEM cells was investigated. The two analogues did not exhibit acute or delayed toxicity (2 weeks exposure) up to 1000~lM. In contrast, at a concentration as low as 0.125~lM of 2' )'-dideoxycytidine (ddC; control druq], the doubling time of the cells increased after 10 days. At higher concentrations, a very marked increase in doubling time was observed from 6 days onward with ddC treatment. The data suggest that in uninfected cells neitherMMdUrd nor MMdCyd are anabolized to the triphosphate Form in signiFicant amounts. As a result, little or no MMdCTP or MMdUTP builds up in the mitochondria and thus delayed toxicity is not observed.
Keywords:
Methoxymethyl deoxycytidine; methoxymethyl deoxyuridine; DNA polymerase y; delayed cytotoxicity. Antiviral nucleoside analogues (ANA), some of which are used to treat human immunodeficiency virus (e.g. dideoxynucleosides 3'-azido-3'-demcythymidine, AZT; 2',3'-dideoxycytidine, ddC; and 2',3'-dideoxyinosine, ddI) and hepatitis B virus infection (e.g. 1-(2-fluoro-2'-deoxy-D-arabinofuranosyl)-5-iodouracil, FIAU; and 2'-deoxy-3'thiacytidine, 3TC) have been shown to exhibit unique multi-organ toxic effects on long-term therapy. The manifestations of toxicity suggest defective mitochondrial DNA (mtDNA) due to inhibition of mtDNA polymerase y.
The manifestations in selected tissues of ANA toxicity during long-term therapy is owing to the combined effects of four principal factors: (i) the subcellular availability and abundance of the ANA in target tissue; (ii) the ability of cellular thymidine kinase/deoxycytidine kinase to phosphorylate ANA to monophosphate intracellularly, and other cellular enzymes to convert ANA monophosphate to ANA triphosphate (via ANA diphosphate); (iii) the ability of ANA triphosphate to inhibit DNA polymerase y either by serving as a competitive alternative substrate and incorporating into mtDNA or by terminating the nascent mtDNA chain (chain termination); and (iv) the metabolic requirements in the target tissues for oxidative phosphorylation. According to the mtDNA polymerase y hypothesis, the cellular enzymes (thymidine kinase and deoxycytidine kinase) play a critical role in mtDNA toxicity because these enzymes phosphorylate ANA to the monophosphate (Chen & Cheng, 1989; Lewis et al., 1992; Lewis & Dalakas, 1995; Parker & Cheng, 1994; Tsai et al., 1994; Wallace, 1992; Wright & Brown, 1990) .
High concentrations of a drug like ddC produce acute toxicity in CEM cells and this may be due to incorporation of ddC into nuclear DNA. In addition, very low concentrations of ddC resulted in depletion of mtDNA MMdUTP and MMdCTP were synthesized and their substrate properties for mtDNA polymerase y were investigated.
CEM cells (lymphoblastoid cell line) were grown in RPMI 1640 medium supplemented with 5% fetal bovine serum. To determine the effect of nucleoside analogues on cell growth, the cells (2x10 5 cells mL-1) were incubated with various concentrations of MMdCyd, MMdUrd and ddC (positive control). The culture medium was changed every 2 days, fresh drug added and the cells (2x10 5 cells mL-1) were resuspended in the medium. Incubation was continued for 14 days. The cell number on alternate days was determined by a Coulter counter. Doubling time was calculated using the formula: number of population dou-
where No is the cell number at the beginning ofthe period; N is the cell number at the end of the period; T No is the time at the beginning of the period; TN is the time when cells were counted.
DNA polymerase y was purified from the crude mitochondrial fraction of myelogenous leukaemia cells by the procedure described previously (Kukhanova et al., 1996) . The purification procedure included the following chromatography steps: DE-52 cellulose, phosphocellulose, heparin and finally ssDNA cellulose. The ability to use poly(rA)'oligo(dT) as template and primer, and high sensitivity to ddCTP indicated that the DNA polymerase activity was that of polymerase y.
Incorporation of MMdUTP and MMdCTP into the 3'-end of primer annealed with DNA polymerase y was carried out using a reaction mixture containing 20 mM Tris-HCI buffer pH 8.0, 6 mM MgCI 2 , 1 mM DTT, 80 mM KCI, 0.5 mM EDTA and 0.1 /lM 5 U 2P-labelled primer-template complex. Various concentrations of dNTP and other analogues were added (see below) and reaction was started by the addition of 2 units of enzyme. The reaction mixture was incubated for 20 min at 37°C and products of primer extension were subjected to 15% polyacrylamide-8 M urea gel electrophoresis. One unit of enzyme activity is defined as the amount of enzyme needed to incorporate 1 nmol of dTMP h-1 into the acidinsoluble fraction at 3TC. The triphosphates ofMMdUrd and MMdCyd were synthesized by the procedure described previously (Aduma et al., 1991 (Aduma et al., , 1992 .
The results of cytotoxicity studies in CEM cells are shown in Fig. 1 . MMdCyd and MMdUrd were tested at concentrations of 125, 250, 500 and 1000~LM (only the 1000 /lM results are shown). The two compounds did not exhibit acute or delayed cytotoxicity after 2 weeks exposure at any of the concentrations tested. On the other hand, a concentration as low as 0.125~of the ddC caused the doubling time of the cells to increase after 10 days. At higher concentrations, a very marked increase in doubling time was observed from 6 days onward with ddC treat- and induced delayed cytotoxicity in cell cultures (Chen & Cheng, 1989 , 1992 Chen et al., 1991) . This depletion of mtDNA may be responsible for the delayed toxicity of ddC observed in humans (Chen & Cheng, 1992) . The fluorinated analogue of uracil (FIAU) and cytosine (FIAC) are potent inhibitors of herpes simplex virus (HSV; Watanabe et al., 1979) and hepatitis virus (Staschke et al., 1994) replication. Clinical trials ofFIAU against hepatitis B virus ended prematurely because of serious delayed toxicities (MacIlwain, 1993; Parker & Cheng, 1994) . Metabolic studies on FIAU using human cell lines suggest that the toxicity of FIAU is associated with its phosphorylation and incorporation into DNA (Klecker et al., 1994) . The compounds 5-methoxymelthyl-2'-deoxyuridine (MMdUrd) and 5-methoxymethyl-2'-deoxycytidine (MMdCyd) are potent, selective antiherpesvirus agents with low cytotoxicity (Aduma et al., 1990; Ayisi et al., 1980 Ayisi et al., ,1986 Meldrum et al., 1980) . Our hypothesis is that MMdCyd and MMdUrd would be anabolized by viral and cellular enzymes in HSV-infected cells to their triphosphate form, which is the 'active' form of the drugs responsible for antiviral activity. The lack of cytotoxicity against rapidly dividing cells (Aduma et al., 1990; Ayisi et al., 1980) indicates that MMdCyd and MMdUrd are not anabolized in uninfected cells because these nucleoside analogues most likely do not serve as substrates for cellular deoxycytidine kinase or thymidine kinase, respectively. To test this hypothesis, MMdCyd and MMdUrd were evaluated for acute cellular toxicity (growth inhibition within 2-3 days) and delayed cytotoxicity (14 days exposure) using human CEM cells. The triphosphates ment. These results are in agreement with studies published previously (Chen & Cheng, 1992) . The results of MMdCTP and MMdUTP incorporation into primer-template complex by DNA polymerase y are shown in Fig. 2 . As can be seen, DNA polymerase y was able to utilize both analogues as substrates and incorporate them into DNA instead of dCTP and dTTP, respectively. The efficiency of incorporation and elongation with analogues was close to that of natural dNTP. The results of the incorporation studies were expected since we have previously shown that both MMdCTP and MMdUTP are good substrates for Esherichia coli, HSV-1 and human DNA polymerase a (Aduma et al., 1991 (Aduma et al., , 1992 . On the basis of these results it would be expected that both MMdCyd and MMdUrd would exhibit delayed cytotoxicity. As shown in Fig. 1, this is not the case. The most likely reason for these observations is that in uninfected cells neither MMdUrd nor MMdCyd is converted to the triphosphate form in significant amounts. As a result, little or no MMdCTP or MMdUTP builds up in the nucleus or mitochondria and thus acute or delayed cytotoxicity is not observed. The subtle differences in nucleoside structure obviously have a profound influence upon the anabolism, as well as pharmacological effects of the compounds. Further studies on the cellular and Antiviral Chemistry & Chemotherapy8 (5) molecular pharmacology of MMdCyd are planned when radioactive substrates become available.
